Canopy Growth Corporation (CGC)
NASDAQ: CGC · Real-Time Price · USD
1.130
-0.090 (-7.38%)
At close: Jul 1, 2025, 4:00 PM
1.160
+0.030 (2.65%)
After-hours: Jul 1, 2025, 7:37 PM EDT
Canopy Growth Revenue
In the fiscal year ending March 31, 2025, Canopy Growth had annual revenue of 269.00M CAD, down -9.47%. Canopy Growth had revenue of 65.03M in the quarter ending March 31, 2025, a decrease of -10.66%.
Revenue (ttm)
269.00M CAD
Revenue Growth
-9.47%
P/S Ratio
1.23
Revenue / Employee
280,203 CAD
Employees
960
Market Cap
230.95M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 269.00M | -28.15M | -9.47% |
| Mar 31, 2024 | 297.15M | -36.11M | -10.83% |
| Mar 31, 2023 | 333.25M | -142.45M | -29.94% |
| Mar 31, 2022 | 475.70M | -70.95M | -12.98% |
| Mar 31, 2021 | 546.65M | 147.88M | 37.08% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
CGC News
- 6 days ago - Here Is A List Of 3 Canadian Marijuana Stocks To Watch 2025 - MarijuanaStocks
- 14 days ago - 3 Canadian Cannabis Stocks Traders Are Watching Closely This Week - MarijuanaStocks
- 20 days ago - 3 Marijuana Stocks For Longterm Investors - MarijuanaStocks
- 4 weeks ago - SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Canopy Growth - GlobeNewsWire
- 4 weeks ago - CGC Shareholders Have the Right to Lead the Canopy Growth Corporation Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - CGC - PRNewsWire
- 4 weeks ago - Canopy Growth Corporation (CGC) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Canopy Growth Reports Fourth Quarter and Fiscal Year 2025 Financial Results - Business Wire
- 4 weeks ago - Canopy Growth Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - Benzinga